Towards personalized therapy in AML: In vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AML von Bernot, KM, Siebenaler, RF, Whitman, SP, Zorko, NA, Marcucci, GG, Santhanam, R, Ahmed, EH, Ngangana, M, McConnell, KK, Nemer, JS, Brook, DL, Kulp, SK, Chen, CS, Frankhouser, D, Yan, P, Bundschuh, R, Zhang, X, Dorrance, AM, Dickerson, K, Jarjoura, D, Blum, W, Marcucci, G, Caligiuri, MA

Volltext